Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

www.Marke...
Introduction to Report
 Launch Date: February 7, 2014
 Number of Pages: 101

 Geography Coverage: Global
 Available Fo...
About the Report
The systemic psoriasis treatment market value in the
eight major countries (8MM) — the US, Canada, France...
Research Findings
Leading analyst of the research team says: “This growth
in the treatment population will be driven by a...
Research Findings Continues…
Although some revenue losses are anticipated to occur
throughout the forecast period, due to...
Scope
An
introduction
to
psoriasis,
which
includes
symptoms, epidemiology, etiology, pathophysiology, diagnosis
and treat...
Reasons To Buy
Understand the current systemic psoriasis marketed
products landscape and recognize the dominant
therapeut...
Report Coverage

1.
2.
3.
4.
5.
6.
7.

Table of Contents
Introduction
Marketed Products
Pipeline
Market Forecast to 2020
C...
Custom Research:
 Are you an industry
professional, entrepreneur, venture capitalist, investors
and organization, then le...
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://www.marketresear...
Upcoming SlideShare
Loading in …5
×

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth

399 views

Published on

Systemic Psoriasis Therapeutics: Increased Disease Awareness and Promising Novel Drugs to Drive Market Growth by 2020, More information visit- http://mrr.cm/Zky

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
399
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth

  1. 1. Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners. www.MarketResearchReports.com
  2. 2. Introduction to Report  Launch Date: February 7, 2014  Number of Pages: 101  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 3,500 Price For Site License: USD 7,000 Price For Global User License: USD 10,500 Delivery Time: Within 24 Hours (During Working Days) www.MarketResearchReports.com
  3. 3. About the Report The systemic psoriasis treatment market value in the eight major countries (8MM) — the US, Canada, France, Germany, Italy, Spain, the UK and Japan — is expected to more than double in the near future, jumping from $5 billion in 2013 to $10.4 billion by 2020, at a significant Compound Annual Growth Rate (CAGR) of 11.1%. The report states that across the 8MM, 4.1 million people were diagnosed with some form of moderate-to-severe psoriasis in 2013. This number is expected to climb slightly to 4.4 million by 2020, with 1.5 million of the population being treated with systemic agents. www.MarketResearchReports.com
  4. 4. Research Findings Leading analyst of the research team says: “This growth in the treatment population will be driven by a marginal rise in the global prevalence of psoriasis, as well as an increase in the diagnosis rate resulting from higher disease awareness and improved diagnostic methods. “Additionally, psoriasis is increasingly being recognized as a serious systemic disease with associated quality of life impairment and disability, rather than as a simply cutaneous disease. As perceptions of psoriasis continue to change, healthcare professionals will consider treatment as non-optional.” www.MarketResearchReports.com
  5. 5. Research Findings Continues… Although some revenue losses are anticipated to occur throughout the forecast period, due to patent expiries, the introduction of new, novel biologics with positive efficacy profiles will drive further market growth. According to report, secukinumab, brodalumab and ixekizumab are three particularly promising, late-stage pipeline monoclonal antibodies directly targeting IL–17, a pro-inflammatory cytokine. In addition to these upcoming biologics, some orally administered, small molecule compounds are also expected to enter the market over the coming years, such as Xeljanz, a janus kinase inhibitor, and apremilast, a PDE4 inhibitor. www.MarketResearchReports.com
  6. 6. Scope An introduction to psoriasis, which includes symptoms, epidemiology, etiology, pathophysiology, diagnosis and treatment Analysis of the major systemic therapies in the current psoriasis marketed landscape Analysis of the pipeline for psoriasis, which includes a breakdown of pipeline molecules by phase of development, molecule type, molecular target and novelty. Psoriasis clinical trials are analyzed by size, duration and failure rates, and a comparative analysis of the most promising systemic pipeline molecules is also provided. Forecast projections for the systemic psoriasis market to 2020. Analysis is provided for the global market and each of the eight major markets. The forecast incorporates projected, low and high variance scenarios based on treatment usage patterns and annual therapy costs in each of the major markets. Analysis of strategic consolidations, including co-development and licensing deals, within the psoriasis indication www.MarketResearchReports.com
  7. 7. Reasons To Buy Understand the current systemic psoriasis marketed products landscape and recognize the dominant therapeutic agents and pharmaceutical players involved Identify trends and developments within the psoriasis pipeline and consider how the future competitive environment will be impacted Consider market opportunities and potential risks by examining the psoriasis clinical trial landscape in relation to industry averages Observe projections for treatment usage patterns, annual therapy costs and market growth in the eight major markets and understand reasons for variance in projected patterns of growth in the eight major markets www.MarketResearchReports.com
  8. 8. Report Coverage 1. 2. 3. 4. 5. 6. 7. Table of Contents Introduction Marketed Products Pipeline Market Forecast to 2020 Co-development and Licensing deals Appendix For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners. www.MarketResearchReports.com
  9. 9. Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center www.MarketResearchReports.com
  10. 10. How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://www.marketresearchreports.com/gbiresearch/systemic-psoriasis-therapeutics-majordeveloped-markets-2020-continued-uptake-biologics About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +1 302-703-7787 (USA) +91-8762746600 (India) www.MarketResearchReports.com

×